Source: International Congress 2016 – Inflammatory biomarkers in airway diseases
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Christof J. Majoor (Baarn, Netherlands), Christof J. Majoor, Marlous S. Sneeboer, Anne de Kievit, Joost C.M. Meijers, Tom van der Poll, Rene Lutter, Pieter Willem Kamphuisen, Elisabeth H. Bel. Eosinophilic inflammation amplifies the prednisolone-induced prothrombotic state in asthma. Eur Respir J 2016; 48: Suppl. 60, 493

Member's Comments

No comment yet.

Related content which might interest you: Induced sputum lipid mediators in severe asthma Source: International Congress 2016 – Translational studies in lung disease Year: 2016 Systemic inflammation, comorbidities and the outcome of adult-onset asthma Source: International Congress 2015 – Clincal aspects of asthma: monitoring and mechanisms Year: 2015 Implication of IL-18 in the chronic inflammation of severe refractory asthma Source: International Congress 2014 – Systemic and airway biomarkers Year: 2014 Correlation of inflammatory markers of disease with sputum neutrophilia in severe asthma Source: International Congress 2015 – Exploring mechanisms in obstructive airway diseases Year: 2015 Effect of systemic inflammation and multi-morbidity on outcome of adult-onset asthma Source: International Congress 2016 – Asthma management Year: 2016 Analysis of the inflammatory profile of children with controlled and uncontrolled severe asthma Source: International Congress 2016 – Drugs, bugs, BMI, and other problems in paediatric asthma Year: 2016 Markers of eosinophilic airway inflammation in patients with severe and mild to moderate asthma Source: International Congress 2016 – Airway biomarkers Year: 2016 Treating peripheral eosinophilia in asthma: Simple and effective Source: Annual Congress 2013 –Systemic and airway biomarkers in respiratory diseases Year: 2013 Obesity influences inflammatory phenotype mainly in early onset severe asthmatics Source: International Congress 2014 – The assessment of comorbidities Year: 2014 Features of inflammation in the asthma patients with osmotic airway hyperresponsiveness Source: International Congress 2015 – New insights into lung disease pathogenesis Year: 2015 Coagulation activity increases with disease severity in patients with asthma Source: International Congress 2015 – Immune aspects of asthma and other airway diseases Year: 2015 Distribution of sputum cellular phenotype in a large asthma cohort. Predicting factors for eosinophilic vs neutrophilic inflammation Source: Annual Congress 2013 –Asthma and COPD: diseases with different phenotypes Year: 2013 Late-onset hypereosinophilic asthma accompanied by systemic eosinophilic manifestations Source: International Congress 2016 – Clinical studies in asthma and immunology Year: 2016 Effect of a 10-day oral corticosteroid course on hemostasis and inflammation in patients with stable asthma Source: International Congress 2015 – Safety of and interactions between current treatments for asthma and COPD Year: 2015 Interleukin-33 and Th2 cytokines correlate in acute asthma Source: International Congress 2016 – Clinical and molecular studies in asthma Year: 2016 Modulation of inflammation by benralizumab in eosinophilic airway disease Source: International Congress 2016 – Novel mechanisms and treatment modalities in asthma Year: 2016 Effect of roflumilast on airway remodeling in a murine model of chronic asthma Source: International Congress 2015 – New models for treating airway diseases Year: 2015 Relation of hemogram parameters with asthma Source: International Congress 2015 – Asthma and lung immunology Year: 2015 Systemic cytokine signaling via IL-17 and its relation to clinical characteristics in children with asthma Source: International Congress 2015 – Paediatric asthma and allergy: lung function and biomarkers Year: 2015 Systemic coagulation increases with asthma severity Source: International Congress 2014 – Novel approaches to human studies in allergy and asthma Year: 2014